Prevalence of Prader-Willi syndrome among infants with hypotonia

The Journal of Pediatrics
Beyhan TuysuzNihan Erginel-Unaltuna

Abstract

To investigate the prevalence of Prader-Willi syndrome (PWS) in infants with hypotonia between the ages of 0 and 2 years. Karyotyping studies were performed in all infants with hypotonia. The study group was composed of infants with hypotonia for whom the karyotyping was found to be normal. Fluorescence in situ hybridization and methylation analysis were performed simultaneously in the study group. Molecular studies for uniparental disomy were undertaken in the patients without deletions with an abnormal methylation pattern. Sixty-five infants with hypotonia with a mean age of 8 months were enrolled. A deletion was detected in 6 patients by fluorescence in situ hybridization analysis. Only 1 patient had no deletion but had an abnormal methylation pattern. A maternal uniparental disomy was observed in this patient. PWS was diagnosed in 10.7 % (7/65) of the infants with hypotonia. The prevalence of PWS syndrome is high among infants with hypotonia. PWS should be considered by pediatricians and neonatologists in the differential diagnosis of all newborns with hypotonia. Early diagnosis of PWS is important for the management of these patients.

References

Feb 1, 1995·Journal of Medical Genetics·G Gillessen-KaesbachB Horsthemke
Apr 1, 1996·The European Respiratory Journal·W T McNicholas
Sep 4, 1998·European Journal of Pediatrics·H A WollmannM B Ranke
Aug 3, 2001·Pediatric Neurology·L P RicherS P Miller
Apr 12, 2003·Brain & Development·Heather M Johnston
Sep 18, 2003·Brain & Development·Asuri N Prasad, Chitra Prasad
Dec 18, 2003·European Journal of Human Genetics : EJHG·Annick VogelsJ P Fryns
Dec 25, 2003·Trends in Endocrinology and Metabolism : TEM·Anthony P Goldstone
Oct 14, 2004·Journal of Biochemistry and Molecular Biology·Daniel BorelinaIrene Szijan
Jul 26, 2005·Expert Reviews in Molecular Medicine·Douglas C Bittel, Merlin G Butler
Mar 18, 2008·Seminars in Pediatric Neurology·John B Bodensteiner
Dec 3, 2008·Developmental Medicine and Child Neurology·Susan R Harris
Aug 12, 2009·Clinical Ophthalmology·Ottar Sjaastad
Dec 22, 2009·Journal of Pediatric Endocrinology & Metabolism : JPEM·A CrinòUNKNOWN Italian Society of Pediatric Endocrinology and Diabetology
Dec 7, 2010·Seminars in Fetal & Neonatal Medicine·A N Prasad, C Prasad
Jan 13, 2012·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Suzanne B CassidyDaniel J Driscoll
Jun 2, 2012·Neuroscience and Biobehavioral Reviews·Linda ReusMaria W G Nijhuis-van der Sanden
Nov 8, 2012·Journal of Obesity·Grechi ElenaChiumello Giuseppe
Apr 2, 2013·The Journal of Clinical Endocrinology and Metabolism·Cheri L DealUNKNOWN 2011 Growth Hormone in Prader-Willi Syndrome Clinical Care Guidelines Workshop Participants
Oct 29, 2013·Archives of Disease in Childhood·Nicola Bridges

❮ Previous
Next ❯

Citations

Oct 18, 2015·Neuroscience and Biobehavioral Reviews·Joanne GriggsMichael L Mathai
Dec 30, 2015·North American Journal of Medical Sciences·Joanne L GriggsMichael L Mathai
Jun 5, 2015·Clinics in Perinatology·Anne Slavotinek, Marwan Ali
Jan 19, 2016·Diseases·Olivia S EdgarMohamad Guftar Shaikh
Jul 1, 2017·Orphanet Journal of Rare Diseases·Céline BarMaithé Tauber
Mar 1, 2015·Expert Review of Endocrinology & Metabolism·Angela K Lucas-HeraldM Guftar Shaikh
Mar 17, 2021·Expert Review of Endocrinology & Metabolism·Alessandro SalvatoniMassimo Agosti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.